title: Seq-ing Markers of Midbrain Dopamine Neurons.
abstract: Transplantation of human pluripotent stem cell-derived dopaminergic neurons is a promising approach to treating Parkinson's disease. In this issue of Cell Stem Cell, Kee et al. (2017) and Kirkeby et al. (2017) identify specific markers of midbrain dopaminergic progenitors to improve their derivation and predict dopamine neuron content after engraftment.
authors.affiliation: Neuroregeneration Research Institute, McLean Hospital / Harvard Medical School, Belmont, MA 02478, USA.
authors.forename: Teresia
authors.initials: T
authors.lastname: Osborn
authors.affiliation: Neuroregeneration Research Institute, McLean Hospital / Harvard Medical School, Belmont, MA 02478, USA. Electronic address: phallett@mclean.harvard.edu.
authors.forename: Penelope J
authors.initials: PJ
authors.lastname: Hallett
mesh_terms: D015415:Biomarkers / Q000378:metabolism*; D059290:Dopaminergic Neurons / Q000166:cytology / Q000378:metabolism* / Q000637:transplantation; D006801:Humans; D008636:Mesencephalon / Q000166:cytology*; D039904:Pluripotent Stem Cells / Q000166:cytology / Q000378:metabolism; D017423:Sequence Analysis, RNA; D057170:Translational Research, Biomedical
chemical_list: D015415:Biomarkers